Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine with or without ketamine for postoperative analgesia after ACL reconstruction
ChiCTR1900023867Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine and ketamine in postoperative pain (3 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoints: Postoperative NRS pain score at 48 hours and AUC of NRS values. Started Jun 2019; status: recruiting.
02
Drugs
ropivacaineketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR1900023867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023867.